COPD: can prevention be improved? Proposal for an integrated intervention strategy.

[1]  M. Mckee,et al.  Understanding the toll of premature death among men in eastern Europe , 2001, BMJ : British Medical Journal.

[2]  K. Berhane,et al.  Effects of in utero and environmental tobacco smoke exposure on lung function in boys and girls with and without asthma. , 2000, American journal of respiratory and critical care medicine.

[3]  R. Pauwels.  COPD: the scope of the problem in Europe. , 2000, Chest.

[4]  T. Petty,et al.  Scope of the COPD problem in North America: early studies of prevalence and NHANES III data: basis for early identification and intervention. , 2000, Chest.

[5]  P. Stang,et al.  The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. , 2000, Chest.

[6]  P. Calverley,et al.  COPD: early detection and intervention. , 2000, Chest.

[7]  N. Voelkel.  Raising awareness of COPD in primary care. , 2000, Chest.

[8]  S. Ramsey,et al.  The economic burden of COPD. , 2000, Chest.

[9]  W. Bailey,et al.  Smoking cessation and lung function in mild-to-moderate chronic obstructive pulmonary disease. The Lung Health Study. , 2000, American journal of respiratory and critical care medicine.

[10]  D. Postma,et al.  Asthma attacks with eosinophilia predict mortality from chronic obstructive pulmonary disease in a general population sample. , 1999, American journal of respiratory and critical care medicine.

[11]  D. Postma,et al.  Risk factors for growth and decline of lung function in asthmatic individuals up to age 42 years. A 30-year follow-up study. , 1999, American journal of respiratory and critical care medicine.

[12]  J C Jager,et al.  Current and future medical costs of asthma and chronic obstructive pulmonary disease in The Netherlands. , 1999, Respiratory medicine.

[13]  D. Postma,et al.  Smoking and airway hyperresponsiveness especially in the presence of blood eosinophilia increase the risk to develop respiratory symptoms: a 25-year follow-up study in the general adult population. , 1999, American journal of respiratory and critical care medicine.

[14]  J. Vestbo,et al.  Socioeconomic status, lung function and admission to hospital for COPD: results from the Copenhagen City Heart Study. , 1999, The European respiratory journal.

[15]  D. Mannino,et al.  Worldwide epidemiology of chronic obstructive pulmonary disease. , 1999, Current opinion in pulmonary medicine.

[16]  W. Morgan,et al.  Maternal smoking and infant lung function. Further evidence for an in utero effect. , 1998, American journal of respiratory and critical care medicine.

[17]  B Rosner,et al.  Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. , 1998, American journal of respiratory and critical care medicine.

[18]  K. Amoli.  Bronchopulmonary disease in Iranian housewives chronically exposed to indoor smoke. , 1998, The European respiratory journal.

[19]  S. Evans,et al.  Population based study of risk factors for underdiagnosis of asthma in adolescence: Odense schoolchild study. , 1998, BMJ.

[20]  Scott T Weiss,et al.  Airways responsiveness and development and remission of chronic respiratory symptoms in adults , 1997, The Lancet.

[21]  Alan D. Lopez,et al.  Evidence-Based Health Policy--Lessons from the Global Burden of Disease Study , 1996, Science.

[22]  L Goldman,et al.  Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments) , 1996, American journal of respiratory and critical care medicine.

[23]  J. Connett,et al.  Methacholine reactivity predicts changes in lung function over time in smokers with early chronic obstructive pulmonary disease. The Lung Health Study Research Group. , 1996, American journal of respiratory and critical care medicine.

[24]  G. Viegi,et al.  Distribution of bronchial responsiveness in a general population: effect of sex, age, smoking, and level of pulmonary function. , 1995, American journal of respiratory and critical care medicine.

[25]  S. Holgate,et al.  Do lower respiratory tract infections in early childhood cause chronic obstructive pulmonary disease , 1995 .

[26]  W. Bailey,et al.  Effects of Smoking Intervention and the Use of an Inhaled Anticholinergic Bronchodilator on the Rate of Decline of FEV1 , 1994 .

[27]  U. Ackermann-Liebrich,et al.  Passive smoking exposure in adults and chronic respiratory symptoms (SAPALDIA Study). Swiss Study on Air Pollution and Lung Diseases in Adults, SAPALDIA Team. , 1994, American journal of respiratory and critical care medicine.

[28]  R. Sharrar,et al.  Passive smoking in obstructive respiratory disease in an industrialized urban population. , 1994, Environmental research.

[29]  D. Dockery,et al.  Longitudinal lung function decline in subjects with respiratory symptoms. , 1992, The American review of respiratory disease.

[30]  K. Godfrey,et al.  Relation of birth weight and childhood respiratory infection to adult lung function and death from chronic obstructive airways disease. , 1991, BMJ.

[31]  M. Silverman,et al.  Lung function in children of low birth weight. , 1989, Archives of disease in childhood.

[32]  G. Baum.  Textbook of Pulmonary Diseases , 1989 .

[33]  F. Speizer,et al.  The natural history of forced expiratory volumes. Effect of cigarette smoking and respiratory symptoms. , 1988, The American review of respiratory disease.

[34]  John F. Murray,et al.  Textbook of Respiratory Medicine , 1988 .

[35]  K L Ebi-Kryston,et al.  Respiratory symptoms and pulmonary function as predictors of 10-year mortality from respiratory disease, cardiovascular disease, and all causes in the Whitehall Study. , 1988, Journal of clinical epidemiology.

[36]  J. Samet,et al.  Health effects and sources of indoor air pollution. Part I. , 1987, The American review of respiratory disease.

[37]  J R Colley,et al.  Early respiratory experience and subsequent cough and peak expiratory flow rate in 36 year old men and women. , 1987, British medical journal.

[38]  T. Beaty,et al.  Robust inference for variance components models in families ascertained through probands: II. Analysis of spirometric measures , 1987, Genetic epidemiology.

[39]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[40]  Ja.  Chronic Obstructive Pulmonary Disease , 1986 .

[41]  M. Wysocki,et al.  The relation of thirteen-year mortality to ventilatory impairment and other respiratory symptoms: the Cracow Study. , 1986, International journal of epidemiology.

[42]  H. Simpson,et al.  Outcome for acute bronchitis, bronchiolitis, and pneumonia in infancy. , 1984, Archives of disease in childhood.

[43]  E. Hey,et al.  Wheezing, asthma, and pulmonary dysfunction 10 years after infection with respiratory syncytial virus in infancy. , 1982, British medical journal.

[44]  J. Lellouch,et al.  Twelve years spirometric changes among Paris area workers. , 1979, International journal of epidemiology.

[45]  M. Lebowitz,et al.  The relationship of childhood respiratory illness to adult obstructive airway disease. , 2015, The American review of respiratory disease.

[46]  K. Offord,et al.  Familial prevalence of chronic obstructive pulmonary disease in a matched pair study. , 1977, The American journal of medicine.

[47]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[48]  A. C. Bryan,et al.  Pulmonary function abnormalities in symptom-free children after bronchiolitis. , 1977, Pediatrics.

[49]  N. P. Dick,et al.  Follow-up evaluation of a prevalence study for chronic bronchitis and chronic airway obstruction. , 1976, The American review of respiratory disease.

[50]  R. K. Larson,et al.  Genetic and environmental determinants of chronic obstructive pulmonary disease. , 1970, Annals of internal medicine.